Lebensbedrohliche Hyperkaliämie infolge einer verzögerten hämolytischen TransfusionsreaktionLife-threatening hyperkalemia due to a delayed hemolytic transfusion reaction

[1] Kovesdy CP(2017)Updates in hyperkalemia: outcomes and therapeutic strategies Rev Endocr Metab Disord 18 41-47

[2] Boureau AS(2019)Blood transfusion in older patients Transfus Clin Biol 26 160-163

[3] de Decker L(2010)A physiologic-based approach to the treatment of acute hyperkalemia Am J Kidney Dis 56 578-584

[4] Shingarev R(2012)Severe hyperkalemia requiring hospitalization: predictors of mortality Crit Care 16 R225-211

[5] Allon M(2007)Risk calculation for hyperkalaemia in heart failure patients Neth J Med 65 208-760

[6] An JN(2019)Hospital-acquired hyperkalemia events in older patients are mostly due to avoidable, multifactorial, adverse drug reactions Clin Pharmacol Ther 105 754-46

[7] Lee JP(2019)Spurious laboratory values in patients with leukocytosis Crit Care Nurs Q 42 44-E240

[8] Jeon HJ(2004)Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies Bull Cancer 91 E229-354

[9] Vereijken TL(2019)Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes Vox Sang 114 349-2029

[10] Bellersen L(2017)Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome Haematologica 102 2021-undefined

[1] Kovesdy CP(2017)Updates in hyperkalemia: outcomes and therapeutic strategies Rev Endocr Metab Disord 18 41-47

[2] Boureau AS(2019)Blood transfusion in older patients Transfus Clin Biol 26 160-163

[3] de Decker L(2010)A physiologic-based approach to the treatment of acute hyperkalemia Am J Kidney Dis 56 578-584

[4] Shingarev R(2012)Severe hyperkalemia requiring hospitalization: predictors of mortality Crit Care 16 R225-211

[5] Allon M(2007)Risk calculation for hyperkalaemia in heart failure patients Neth J Med 65 208-760

[6] An JN(2019)Hospital-acquired hyperkalemia events in older patients are mostly due to avoidable, multifactorial, adverse drug reactions Clin Pharmacol Ther 105 754-46

[7] Lee JP(2019)Spurious laboratory values in patients with leukocytosis Crit Care Nurs Q 42 44-E240

[8] Jeon HJ(2004)Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies Bull Cancer 91 E229-354

[9] Vereijken TL(2019)Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes Vox Sang 114 349-2029

[10] Bellersen L(2017)Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome Haematologica 102 2021-undefined